And I tell the story, Glenn, that in my first term, I had the honor of being the first president in 28 years to lower drug prices during the course of the year. And we actually did. And I was so proud of myself. We called a news conference. I announced it. It was one-eighth of 1 percent. One-eighth of 1 percent.
The national conversation around prescription drug pricing is back in full force. From the recent Most Favored Nation (MFN) executive order to President Trump's letter urging pharmaceutical companies to offer direct-to-consumer (DTC) pricing for brand medications, it's clear we're at a pivotal moment for American healthcare. It's a moment that demands more than just rhetoric; it demands innovation, pragmatism, and above all, deep collaboration across the industry.
